Search research articles
Contact Us
Filters
Showing results (11-20 of 87) with videos related to
Page
of 9
Sort By:
Plos One
|
May 4, 2019
Thermodynamic investigation of DNA-binding affinity of wild-type and mutant transcription factor RUNX1
Fangrui Wu, Tidie Song, Yuan Yao, et al.
Journal of Hematology & Oncology
|
April 9, 2022
A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
Xin Li, Yuan Yao, Fangrui Wu, et al.
Angewandte Chemie (International Ed. in English)
|
August 28, 2014
Regioselective radical aminofluorination of styrenes
Hongwei Zhang, Yongcheng Song, Jinbo Zhao, et al.
Journal of Medicinal Chemistry
|
November 6, 2009
Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase
Lisheng Deng, Sandeep Sundriyal, Valentina Rubio, et al.
ACS Medicinal Chemistry Letters
|
March 8, 2011
Structures of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase/Lipophilic Phosphonate Complexes
Lisheng Deng, Kiwamu Endo, Masahiro Kato, et al.
European Journal of Medicinal Chemistry
|
May 31, 2026
Synthesis, structure-activity relationships, antitumor activities and mechanistic studies of ENL-degrading compounds
Xin Li, Harshavardhan Reddy Kasireddy, Chandra Bhushan Mishra, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1
Fangrui Wu, Chao Zhou, Yuan Yao, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 23, 2013
Expression, characterization and inhibition of Toxoplasma gondii 1-deoxy-D-xylulose-5-phosphate reductoisomerase
Guobin Cai, Lisheng Deng, Jian Xue, et al.
Plos One
|
February 4, 2017
Structure activity relationship and modeling studies of inhibitors of lysine specific demethylase 1
Chao Zhou, Fangrui Wu, Lianghao Lu, et al.
European Journal of Medicinal Chemistry
|
May 5, 2022
Structure-activity relationship and antitumor activity of 1,4-pyrazine-containing inhibitors of histone acetyltransferases P300/CBP
Shenyou Nie, Fangrui Wu, Jingyu Wu, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 87) with videos related to
Sort By:
Page
of 9
Plos One
|
May 4, 2019
Thermodynamic investigation of DNA-binding affinity of wild-type and mutant transcription factor RUNX1
Fangrui Wu, Tidie Song, Yuan Yao, et al.
Journal of Hematology & Oncology
|
April 9, 2022
A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
Xin Li, Yuan Yao, Fangrui Wu, et al.
Angewandte Chemie (International Ed. in English)
|
August 28, 2014
Regioselective radical aminofluorination of styrenes
Hongwei Zhang, Yongcheng Song, Jinbo Zhao, et al.
Journal of Medicinal Chemistry
|
November 6, 2009
Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase
Lisheng Deng, Sandeep Sundriyal, Valentina Rubio, et al.
ACS Medicinal Chemistry Letters
|
March 8, 2011
Structures of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase/Lipophilic Phosphonate Complexes
Lisheng Deng, Kiwamu Endo, Masahiro Kato, et al.
European Journal of Medicinal Chemistry
|
May 31, 2026
Synthesis, structure-activity relationships, antitumor activities and mechanistic studies of ENL-degrading compounds
Xin Li, Harshavardhan Reddy Kasireddy, Chandra Bhushan Mishra, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1
Fangrui Wu, Chao Zhou, Yuan Yao, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 23, 2013
Expression, characterization and inhibition of Toxoplasma gondii 1-deoxy-D-xylulose-5-phosphate reductoisomerase
Guobin Cai, Lisheng Deng, Jian Xue, et al.
Plos One
|
February 4, 2017
Structure activity relationship and modeling studies of inhibitors of lysine specific demethylase 1
Chao Zhou, Fangrui Wu, Lianghao Lu, et al.
European Journal of Medicinal Chemistry
|
May 5, 2022
Structure-activity relationship and antitumor activity of 1,4-pyrazine-containing inhibitors of histone acetyltransferases P300/CBP
Shenyou Nie, Fangrui Wu, Jingyu Wu, et al.
Page
of 9